NCT00725764 2017-10-16Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and NeckGlaxoSmithKlinePhase 2 Completed14 enrolled 14 charts
NCT00725712 2017-08-24Study of GSK1363089 in Metastatic Gastric CancerGlaxoSmithKlinePhase 2 Completed74 enrolled 22 charts